TPx Treatment Pathways

Our proprietary TPx Treatment Pathways empower oncologists to utilize the latest advancements in drug development and genomic science to select highly individualized, patient-specific treatment approaches.

The TPx Treatment Pathways are developed through the collaborative efforts of scientists and physicians from Genesis, leading academic physicians for each cancer type and representatives from oncology practices around the country. Taking into consideration the current, evidence-based practice of oncology, the pathways address all stages of cancer; include information about the clinical, imaging, laboratory testing and genetic testing information required to make therapeutic decisions; and are updated regularly to ensure the most cutting-edge view of the changing knowledge landscape.

The therapeutic pathways are easily accessible to members of the Genesis Oncology Network.

Available Treatment Pathways

The TPx Treatment Pathways span a wide range of major cancers and cancer subtypes, and deal with multiple stages and lines of therapy. The list below is a summary of the TPx Pathways currently available for oncologistsí use, including pathways for many high-incidence diseases.

  • Breast cancer
  • Colorectal cancer
  • Lung cancer
  • Melanoma
  • Thyroid cancer
  • Pancreatic cancer
  • Lymphoma

Additional pathways are currently in development.

How it works
Get started online and submit inquiry form.
We will contact your physician who will receive a Genesis kit.
Use the kit to submit a saliva specimen with your physician who will send it to Genesis.
Within two weeks, you will get a mail that your results are available with your physician.